Glytec has partnered with Adventist Health System to bring its eGlycemic diabetes management system to 39 of the health system’s acute care facilities. Glytec’s cloud-based eGMS will become a part of the standard of care for patients who need insulin therapy, in both the critical care units and on the medical-surgical floor, the companies said. […]
Hospital Care
Baxter launches asset tracking system for infusion pumps
Baxter (NYSE:BAX) today launched the DeviceVue asset tracking solution for hospitals using its Sigma Spectrum infusion system. The product was designed to help clinicians and biomedical engineers quickly find unused pumps by viewing pump location and status data from their computers or phones. The company said it is the first and only smart infusion pump manufacturer to […]
BD launches fully-automated diagnostic to fight antimicrobial resistance in Europe
Becton Dickinson (NYSE: BDX) today launched the first automated phenotypic diagnostic test for infections caused by carbapenemase-producing organisms. The new BD Phoenix CPO test is available as part of the BD Phoenix automated microbiology system in Europe, the company said, and is designed to help hospitals detect and contain infections caused by CPOs. Carbapenemase-producing organisms are resistant […]
Medtech stories we missed this week: Sept. 22, 2017
From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, […]
Medtech stories we missed this week: September 8, 2017
From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention. 1. BrainScope to develop pediatric traumatic brain injury assessment device BrainScope announced in a Sept. 7 press release that it will immediately start creating […]
Study: Opioid-related deaths overwhelming intensive care units
Intensive care units in hospitals have seen a sharp increase in the number of opioid-related admissions and deaths since 2009, according to a study by researchers at Beth Israel Deaconess Medical Center, and the demand for care relating to opioids has overwhelmed the available supply. The team touted their study, which was published today in […]
Medtech stories we missed this week: August 11, 2017
From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions […]
Rebiotix launches late-stage superbug trial for microbiome-based drug
Rebiotix isn’t a traditional drugmaker. Its products are alive. The 32-person company, based in Roseville, Minn., is developing a microbiome-based therapy to prevent recurrent Clostridium difficile infection. Its Microbiota Restoration Therapy, which is delivered via enema or a lyophilized, non-frozen oral capsule, is designed to supply a patient’s intestinal tract with an array of healthy, human-derived microbes. […]
Milestone Scientific wants to bring subcutaneous injections into the 21st century
As a dentist, Mark Hochman gave countless injections to his patients and watched as many of them would cringe from pain. Frustrated with a technology that he said hasn’t improved in decades, he decided to take a different approach to the common method of drug delivery. “A team of us got together to evaluate whether […]
OpGen prices $10m public offering
OpGen (NSDQ:OPGN) said earlier this month that it priced a $10 million public offering of 25 million units of common stock and warrants at 40¢ apiece. The molecular diagnostics company said each common warrant has an exercise price of 43¢ per share and expires five years after issuance. The offering is slated to close tomorrow. […]